Drug Topics
AUGUST 21, 2024
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
PharmaVoice
AUGUST 19, 2024
With fewer side effects, the new wave of upcoming drugs could improve patient adherence, and the competition for a large projected market is getting fierce.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 23, 2024
The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.
STAT
AUGUST 23, 2024
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 19, 2024
The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.
PharmaVoice
AUGUST 20, 2024
Dr. Jennifer Low, head of 23andMe’s therapeutics division, is taking the company into new territory with a potential cancer treatment that targets a unique pathway.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 21, 2024
Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had been vaccinated at least 10 days before being exposed to the virus, a new study reports. An earlier study had shown that people who were vaccinated but went on to develop the disease were more likely to survive the infection.
Drug Topics
AUGUST 21, 2024
Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.
Fierce Healthcare
AUGUST 20, 2024
Health IT giant Epic is pushing ahead rapidly to build out artificial intelligence technologies and generative AI features in its electronic health record software. | The goal, according to Epic executives, is to ease the documentation burden for clinicians, streamline charting and coding and bring evidence-based medical insights and research right to doctors' fingertips at the point of care.
Pharmacy Times
AUGUST 18, 2024
Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
AUGUST 21, 2024
Rachel Gross wants to clear up misconceptions about children and Covid-19. A pediatrician and population health researcher, she recalls a time four years ago when people didn’t think children could even contract the disease. Then, after accepting kids’ vulnerability to the virus, it was thought only adults could suffer from the myriad symptoms that persist or crop up post-infection, collectively known as long Covid.
Drug Topics
AUGUST 19, 2024
A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.
Fierce Healthcare
AUGUST 23, 2024
The healthcare industry confronts a complex, double-barreled challenge as it tries to combat the recent deluge of dangerous and damaging cyberattacks. | Cyber resilience is the ability to recognize threats, respond to them, recover quickly and at scale. The clear goal: fending off attacks more efficiently, limiting damage and restoring normal operations with minimal impact to patients.
Pharmacy Times
AUGUST 19, 2024
The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 21, 2024
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer. She and her husband, Ben Burnham, were devastated, physically and financially drained — and deeply frustrated by the lack of answers or support for people like them who had experienced recurrent miscarriages.
Drug Topics
AUGUST 23, 2024
Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.
pharmaphorum
AUGUST 19, 2024
Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network
Pharmacy Times
AUGUST 17, 2024
New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 20, 2024
Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In a Phase 3 trial that lasted over three years, people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to diabetes compared with people on placebo, Lilly said Tuesday.
Drug Topics
AUGUST 21, 2024
A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.
Fierce Healthcare
AUGUST 22, 2024
Employers are actively seeking out alternatives to curb rising health benefit costs by sidestepping traditional carriers, a new report from Brighton Health Plan Solutions shows. | A new report highlights a business opportunity for providers and health systems to engage in direct contracting.
Pharmacy Times
AUGUST 20, 2024
Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.
STAT
AUGUST 19, 2024
Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.
Drug Topics
AUGUST 21, 2024
Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.
Fierce Healthcare
AUGUST 20, 2024
The upward trajectory of Medicare Advantage (MA) enrollment is likely to become an issue for hospitals and other healthcare providers forced to contend with plans’ prior authorization requirements | Prior authorization burdens and "a challenging contract negotiation season" on the horizon are likely headwinds for providers, and hospitals in particular, according to a recent report.
Pharmacy Times
AUGUST 18, 2024
Sara Roszak discusses her role as president of the NACDS Foundation.
STAT
AUGUST 19, 2024
Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank. Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create.
Drug Topics
AUGUST 22, 2024
Novavax is still awaiting FDA authorization for their protein-based COVID-19 vaccine.
Fierce Healthcare
AUGUST 21, 2024
The Centers for Medicare & Medicaid Services (CMS) issued a new report Tuesday detailing total complaints related to the No Surprises Act and Affordable Care Act compliance. | A new CMS report outlines the types of No Surprises Act complaints resolved by the federal agency since June 30.
Pharmacy Times
AUGUST 19, 2024
Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.
STAT
AUGUST 22, 2024
WASHINGTON — U.S. regulators approved updated Covid-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.
Drug Topics
AUGUST 21, 2024
The National Association of Chain Drug Stores is active at both the federal and state levels in advocating for PBM reform.
PharmaVoice
AUGUST 22, 2024
Greg Friberg and James Sabry will take over, respectively, as heads of R&D and business development, less than a year after BioMarin named a new CEO.
Expert insights. Personalized for you.
281 
Let's personalize your content